Significant differences in red blood cell folate levels between best and worst responders to methotrexate in patients with rheumatoid arthritis.

被引：0
|
作者：
Kremer, JM
Davey, BT
Hall, MJ
Lawrence, DA
机构：
[1] Albany Med Coll, Albany, NY 12208 USA
[2] Wadsworth Ctr Labs & Res, Albany, NY 12208 USA
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
753
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [21] Relationship between clinical response, rituximab pharmacokinetics, and peripheral B cell levels in rheumatoid arthritis.
    Breedveld, FC
    Agarwal, S
    Yin, M
    Ng, C
    Li, NF
    Sewell, KL
    Shaw, TM
    Davies, BE
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S138 - S138
  • [22] Aptamer Based Proteomic Profiling Demonstrates Significant Differences in Methotrexate Responders versus Non-responders in Newly Diagnosed Rheumatoid Arthritis and Adds Potential Value to Clinical Examination
    Gu, Kaien
    Lac, Leanne
    Carrier, Nathalie
    O'Neil, Liam
    Boire, Gilles
    Hu, Pingzhou
    Hitchon, Carol
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4487 - 4489
  • [23] Association of Low Baseline Levels of Erythrocyte Folate With Treatment Nonresponse at Three Months in Rheumatoid Arthritis Patients Receiving Methotrexate
    de Rotte, M. C. F. J.
    de Jong, P. H. P.
    Pluijm, S. M. F.
    Calasan, M. Bulatovic
    Barendregt, P. J.
    van Zeben, D.
    van der Lubbe, P. A.
    de Sonnaville, P. B.
    Lindemans, J.
    Hazes, J. M. W.
    de Jonge, R.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (11): : 2803 - 2813
  • [24] The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia
    Oosterom, N.
    Fiocco, M.
    Kloos, R. Q. H.
    van der Sluis, I. M.
    Pieters, R.
    van Zelst, B. D.
    Smith, D. E. C.
    van den Heuvel-Eibrink, M. M.
    de Jonge, R.
    Heil, S. G.
    BMC CANCER, 2020, 20 (01)
  • [25] The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia
    N. Oosterom
    M. Fiocco
    R. Q. H. Kloos
    I. M. van der Sluis
    R. Pieters
    B. D. van Zelst
    D. E. C. Smith
    M. M. van den Heuvel-Eibrink
    R. de Jonge
    S. G. Heil
    BMC Cancer, 20
  • [26] MTHFR polymorphism and red cell folate levels are not useful as biomarkers of methotrexate efficacy and toxicity in children with juvenile idiopathic arthritis
    J Tuková
    M Hroch
    P Doležalová
    Pediatric Rheumatology, 6 (Suppl 1)
  • [27] RED BLOOD CELL DISTRIBUTION WIDTH AS A BIOMARKER OF INFLAMMATION IN RHEUMATOID ARTHRITIS PATIENTS
    Martinez, M.
    Ruffino, J.
    Argento, M.
    Carbone, D.
    Ringer, A.
    Chulibert, S.
    Cuadranti, N.
    Rolla, I.
    Rombo, G.
    Milanesio, J.
    Cortese, N.
    Palatnik, M.
    Lagrutta, M.
    Soldano, J.
    Abdala, M.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 129 - 130
  • [28] Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate
    Boiardi, L
    Macchioni, P
    Meliconi, R
    Pulsatelli, L
    Facchini, A
    Salvarani, C
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (04) : 419 - 425
  • [29] Red blood cell methotrexate polyglutamates emerge as a function of dosage intensity and route of administration during pulse methotrexate therapy in rheumatoid arthritis
    Dervieux, Thierry
    Zablocki, Rong
    Kremer, Joel
    RHEUMATOLOGY, 2010, 49 (12) : 2337 - 2345
  • [30] MEASUREMENTS OF RED BLOOD-CELL METHOTREXATE CONCENTRATIONS AND LYMPHOCYTE SUBSETS DURING THERAPY OF RHEUMATOID-ARTHRITIS
    DUBY, S
    KARSH, J
    PRCHAL, JF
    WHITEHEAD, VM
    OSTERLAND, CK
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1985, 3 (01) : 5 - 9
12345